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Summary  
The effects of high molecular weight hyaluronan (HA) on cartilage degeneration were investigated in a partial 
menisectomy model of osteoarthritis (OA) in the rabbit knee. This study compared HA80 (0.8x 106 Da, 1%), HA190 
(1.9 x 106 Da, 0.01-1%) and saline. HA (0.1 ml/kg) or saline were injected intra-articularly twice a week immediately after 
surgery. Degenerative changes in femoral and tibial cartilages were graded histopathologically 2 and 4 weeks after 
surgery. Two weeks after surgery, HA190, only when used at a 1% concentration, resulted in a dramatic inhibition of 
cartilage degeneration i  both the femoral condyle and the tibial plateau (P < 0.01). Two weeks after surgery, the 
protection against cartilage degeneration was significantly (P < 0.05) greater with HA190 than with HA80. Four weeks 
after surgery, only the femoral cartilage degeneration was significantly and similarly inhibited with HA190 (P < 0.01) 
and HA80 (P < 0.05). Scanning electron micrographs offemoral cartilage showed that cartilage degeneration was less 
severe with HA190 than with saline. These results might suggest that, in the rabbit model, intra-articular dministration 
of higher molecular weight HA is more effective than lower molecular weight HA in inhibiting cartilage degeneration 
in early OA. 
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I n t roduct ion  
OSTEOARTHRITIS (OA) is a common joint disease, 
• characterized by degenerative changes in art icular 
cartilage and reactive proliferation of bone and 
cartilage around the joint. Recent findings indicate 
that OA is not a 'wear and tear'  process, but rather 
a cell-mediated active process that may result 
from the inappropriate r sponse of chondrocytes to
catabolic and anabolic stimuli. Changes in some 
matrix molecules of art icular cartilage reportedly 
occur even in early OA [1, 2]. 
Hyaluronan (HA), a high molecular weight 
polymer of glucosamine and glucuronic acid 
residues, is one of the key components of the 
art icular cartilage matrix. A tert iary macromol- 
ecular complex of aggrecan, link protein, and HA 
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endow art icular cartilage with many specific 
mechanical properties, including viscoelasticity. 
HA is also a major component of the synovial fluid, 
which supplies nutrients to the art icular cartilage 
and lubricates the joints, thereby minimizing 
friction on the surface of th~ articular cartilage. 
Moreover, HA is believed to modulate the function 
of various types of cells, including art icular 
chondrocytes. 
In advanced OA, a significant decrease in HA 
concentration and molecular size in the synovial 
fluid has been documented [3,4]. Because a 
quantitative and qualitative decrease in the 
synovial fluid HA is believed to accelerate cartilage 
destruction in OA, intra-articular HA injection 
therapy has been widely used in the treatment 
of OA. Many clinical investigations on HA 
[5-11] reported symptomatic improvement in OA 
patients. 
The effects of HA on OA have been extensively 
studied in animal models. Toyoshima [12] described 
the effect of HA on cartilage degeneration after 
synovectomy in rabbits. Kitoh et al. [13] described 
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the effect of HA on cartilage degeneration i duced 
by papain injection. Wigren ct al. [14] documented 
the effect of HA on cartilage degeneration i duced 
by joint immobilization. Abatangelo et al. [15] 
and Schiavinato et al. [16] studied the effect of 
HA on cartilage degeneration induced by re- 
section of the anterior cruciate ligament of the 
knee joint. A marked inhibitory effect of HA on 
cartilage degeneration was observed in all these 
studies. 
Several HA preparations with different molecu- 
lar weights have been developed and used for 
intra-articular injection therapy of OA. The 
molecular weight of commercially available HA 
ranges from 8 x 105-7 x 106 Da (8 x 105 Da for Artz ~' 
from Seikagaku Kogyo Co. Ltd. and Hyalgan ® from 
Fidia Co. Ltd., 7xl06Da for Synvisc ® from 
Biomatrix Co. Ltd.). The molecular weight of HA in 
human synovial fluid ranges from 1.6 × 106- 
10.9 x 106 Da [3]. Most human and animal studies 
used a low molecular weight HA (less than 1 × 106) 
obtained from ,rooster combs: Few, if any, studies 
used HA derived from other sources [17]. The 
present study investigated the effects of a high 
molecular weight HA (HA190:1.9 x 10 ~ Da), derived 
from a fermentation process using Streptococcus 
equi. Its efficacy is compared to that of a rooster 
comb HA (HA80) in an experimental rabbit model 
of OA. 
Materials and methods  
ANIMALS AND SURGERY 
A total of 72 male New Zealand White rabbits, 
weighing 2-3 kg, were subjected to the section of 
the fibular collateral and sesamoid ligaments of the 
left knee joint and to the resection of a 3-4 mm 
segment (approximately 30-40%) of the lateral 
meniscus, according to the method reported by 
Colombo et al. [18]. Sixty (10 groups of six) were 
treated with HA and 12 (two groups of six), treated 
with saline were used as controls. Sham operations, 
where ligaments were resected and the joint space 
exposed without subsequent partial meniscectomy, 
were performed on 12 additional animals (two 
groups of six), used as surgical controls. The basic 
design of the study and the assignment of animals 
for treatment and sacrifice are summarized in 
Table I. 
Surgical interventions were performed under 
sodium pentobarbital anesthesia nd in sterile 
conditions. Animals were housed and maintained 
in accordance with the NIH guidelines. At the time 
of death, animals were exsanguinated by carotid 
dissection while under deep sodium pentobarbital 
anesthesia. 
HYALURONAN AND INTRA-ARTICULAR TREATMENT 
HA190 was obtained from Roussel Uclaf Japan 
Co. Ltd. (Tokyo); it was produced by fermentation 
using the lactobacillus Streptococcus equi and then 
purified by ultrafiltration and ethanol precipi- 
tation. HA190 was an amorphous white powder 
with an average molecular weight of 1.9 x 108 Da. 
HA190 was soluble in water, and a 1% solution in 
physiological saline had a neutral pH (6.8-7.8) and 
a high viscosity (23.7-29.7 dl/g at 30°C) [19]. HA80 
was obtained from Seikagaku Kogyo Co. Ltd. 
(Tokyo); it was extracted from rooster combs and 
had an average molecular weight of 0.8 × 106 Da. 
HA190 was dissolved in physiological saline at 
concentrations of 0.01, 0.3, 0.6 or 1% (w/v). HA80 
was dissolved in a 1% physiological saline (w/v). 
The dose injected each time was 0.1ml/kg of 
body weight. HA or saline were injected intra- 
articularly twice a week, immediately after surgery 
until sacrifice at 2 or 4 weeks. 
HISTOPATHOLOGICAL METHODS 
After sacrifice, the femoral condyle and the tibial 
plateau were resected and immediately fixed in 
10% formalin buffer (pH 7.4) containing 0.5% of 
cetylpyridinium chloride. The samples were de- 
calcified in 0.5% EDTA (pH 7.4) and embedded in 
paraffin. To avoid sampling bias, tissue sections 
were always collected from the same anatomical 
site on the condyle and plateau (Fig. 1). The 
femoral condyle was cut into coronal sections in 
the plane posterior to the attachment point of the 
popliteus tendon. The tibial plateau was cut into 
coronal sections in the plane anterior to the 
attachment point of the meniscofemoral ligament. 
Sections were stained with hematoxylin and eosin 
(H&E) for general morphology or Safranin-O (SO) 
for proteoglycan staining. All sections were read 
blindly by one observer. Cartilage degeneration 
was analyzed using the scoring system developed 
by Colombo et al. [18] with minor changes (i.e. bone 
cysts and osteochondr0phytes were excluded, and 
fissures and fibrillations were combined). The 
following eight parameters were graded: loss of 
superficial layer, erosion of cartilage, fibrillation 
and/or fissures, loss of stainable proteoglycan, 
disorganization of chondrocytes, loss of chondro- 
cytes, cluster formation and exposure of subchon- 
dral bone. Each item was graded from 1-4 (Table II). 
The sum of the values of each item was regarded as 
a global histological score. According to the report 
of Colombo et al. [18], the model induced a lateral 
knee joint OA but degenerative cartilage changes 
developed in neither the medial femoral condyle 
nor medial tibial plateau. Therefore, only the 
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Table I. 
Experimental procedures and animal groups 
Group Treatment Duration Concentration (%) N 
HA treated animals 
HA190, biweekly 2 weeks (four injections) 













2 weeks (four injections) 
4 weeks (eight injections) 
2 weeks (four injections) 




cartilage of the lateral femoral condyle and of the 
lateral tibial plateau were histologically examined. 
SCANNING ELECTRON MICROSCOPY (SEM) 
Two representative cartilage specimens from 
sham operated and saline groups and 1% HA190 




Attachment of popliteus tendon 
%iiiiiii4iilii iiiiiiiiiiii!ili!!Iii  
4~tioning site 
Lateral 
Attachment of (b) meniscofemoral ligament 
~ Sectmmng site 
(Anterior) 
FIG. 1. Histopathologically examined sites of the femoral 
condyle and tibial plateau. (a) Femoral condyle was cut 
into coronal sections in the plane just posterior of the 
attachment ofpopliteus tendon. (b) Tibial plateau was 
cut into coronal sections in the plane just anterior of the 
attachment ofmeniscofemoral ligament. 
articular cartilage was trimmed and its surface 
washed with physiological saline. The samples 
were fixed in 2.5% glutaraldehyde and then in 1% 
osmic acid. After dehydration i ethanol solutions 
of increasing concentrations, the samples were 
treated with isoamyl acetate and subjected to 
critical point drying, using an HCP-2 (Hitachi Co. 
Ltd., Tokyo). After vapor deposition of gold using 
an ion sputter (JFC-1100, Nihon Denshi Co. Ltd., 
Osaka), the samples were examined with SEM 
(JSM-840, Nihon Denshi). 
STATISTICAL ANALYSIS 
Histological scores were analyzed by the F-test. 
If they were found to be of equal variance, the data 
were further analyzed by Wilcoxon's rank sum test. 
Differences were considered significant if P ~< 0.05. 
Resu l ts  
GROSS PATHOLOGY 
The resection of only two ligaments did not 
induce gross or histological OA changes. 
Two weeks after surgery, the saline t reated 
animals showed gross cartilage erosion of the 
lateral femoral condyle and of the lateral tibial 
plateau, whereas the medial condyle and the 
plateau cartilage showed no changes. The surface 
area of erosions tended to be smaller in the 1% 
HA190 and HA80 treatment groups than in the 
saline treated group (figure not shown). 
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Table II. 
Method for histopathoIogical evaluation of cartilage degeneration. 
+1 +2 +3 +4 
Loss of superficial < Slight Moderate Focally severe Extensively severe 
layer 
Erosion of cartilage Moderate 
Fibrillation and/or Moderate 
fissures (1 small) 
Loss of proteoglycan 
Disorganization of 
chondrocytes 




Moderate loss of 
safraninophilia 
Moderate, with 





exposure of bone 
5--6 small, 3-4 




(< 1 very small) 













(2 small or 1 
medium) 
Marked loss of 
• safraninophilia 





exposure of bone 
7 or more medium 
or 5-6 large 
Extensively severe 
Extensive 
(3 small, 2 medium 
or 1 large) ~ 





decrease in cells 
Very extensive 
exposure of bone 
7 or more small, 5~ 
medium or 3-4 
large 
HISTOPATHOLOGY 
Two weeks after surgery, the cart i lage from 
the lateral femoral  condyle and from the lateral  
t ibial p lateau of sal ine-treated animals showed 
degenerative changes, including: loss of the 
superficial layer, erosion, f ibri l lat ion and/or  
fissures, loss of stainable proteoglycan, disorganiz- 
ation of chondrocytes,  loss of chondrocytes and 
cluster formation [Fig. 3(a) and (b)]. Exposure of 
subchondral  bone was only rarely seen and the 
areas were quite small. Four weeks after surgery, 
the degenerative changes clearly progressed in the 
carti lage of the lateral  compartment,  while no 
change was shown in the medial compartment  
(Fig. 2). 
Two weeks after surgery, cart i lage degenerat ion 
was mild in the 1% HA190 t reatment  group, 
compared to the sal ine-treated contro l  group, 
i.e. f ibri l lation of the femoral cart i lage was l imited 
and the tibial cart i lage was near ly unchanged 
[Fig. 3(a) and (b)]. Four weeks after surgery, 
cart i lage lesions in the 1% HA190 group were less 
severe than in the sal ine-treated control  group 
[Fig. 3(c) and (d)]. Two and 4 weeks after surgery, 
degenerative changes of  both the tibial and femoral 
cart i lage were observed in the HA80 treated 
groups. The lesions of the HA80 group were less 
severe than in the control  group, but more severe 
than in the 1% HA190 group. 
GLOBAL HISTOPATHOLOGICAL SCORE 
Two and 4 weeks after surgery, the mean global 
score of the femoral condylar  cart i lage was 
signif icantly lower (P < 0.01) in the 1% HA190 
t reatment  group than  in the sal ine-treated group 
(Fig. 4). Two weeks after surgery the mean global 
score of the tibial p lateau cart i lage was also 
signif icantly lower (P < 0.01) in the 1% HA190 
t reatment  group than  in the sal ine-treated group. 
However, the difference between the two groups 
was not stat ist ical ly signif icant 4 weeks after 
surgery. The mean global score of the femoral  
condylar  cart i lage of the animals t reated with 
HA80 and ki l led 4 weeks after surgery was 
signif icantly lower than in the sal ine group 
(P  < 0.05). The mean global scores of the cart i lage 
from both the femoral condyle and the tibial 
p lateau of animals ki l led 2 weeks after surgery 
were signif icantly lower (P<0.05)  in the 1% 
HA190 t reatment  group than in the HA80 
t reatment  group (Fig. 4). 
The protective ffect of HA190 on cart i lage was 
dose and site-dependent. When compared with the 
sal ine groups, the mean global score of the femoral  
condylar  carti lage,,  both at 2 and 4 weeks, was 
signif icantly lower (P < 0.01) with a HA190 only 
with 1%. An except ion was found for 0.6% HA190 
at 4 weeks in the samples of the femoral condylar  
carti lage. With respect to the tibial plateau, a 
statist ical ly signif icant decrease in the mean 
global score was only found with 1% HA190 and 
only at 2 weeks; lower doses of HA190 had no 
signif icant effect (Table III). 
ITEMS OF THE HISTOPATHOLOGICAL SCORE 
The effect of HA on the various items of the 
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histopathological scores is summarized in Table IV. 
With exception of subchondral bone exposure, each 
item of the score had a high grade in femoral and 
tibial cartilage from saline treated animals killed 
at 2 weeks. When compared with the saline group, 
three items of the femoral cartilage score (P < 0.05) 
and five items of the tibial cartilage score 
(P < 0.01) were significantly decreased with 1% 
HA190, 2 weeks after surgery (Table IV). In neither 
the femoral nor in the tibial cartilage, were the 
items significantly modified with HA80. 
Four weeks after surgery, four items of the 
femoral cartilage score (P < 0.05) and one item of 
the tibial cartilage score (disorganization of 
chondrocytes, P < 0.01) were significantly lower in 
the 1% HA190 treatment group than in the saline 
group. (Table IV). In the HA80 treatment group, 
only two items of the femoral cartilage score were 
reduced, compared to the saline treated control 
group 4 weeks after surgery (P < 0.05), and items of 
the tibial cartilage score were unmodified. 
SEM 
Two weeks after surgery, the surface of the 
articular cartilage of animals from the control 
group was smooth and showed no evidence of 
fibrous structure, such as collagen fibers. In 
contrast, the cartilage surface of saline-treated 
animals was roughened with many large fissures, 
exposing collagen fibers of varying sizes in both the 
superficial and deeper layers. Such degenerative 
changes in the cartilage were also bserved in the 
1% HA190 treatment group, but the changes were 
less severe than in the saline-treated control group 
(Fig. 5). 
Discuss ion  
The present study examined the effect of HA 
injections on the course of experimental OA 
induced by the sectioning of the fibular collateral 
and sesamoid ligaments and the partial removing 
of the lateral meniscus in knee joints of adult 
rabbits. Significant destructive cartilage changes, 
quite similar to those observed in human OA, 
were found relatively early after surgery. Severe 
lesions developed within 4 weeks after surgery 
in the saline-treated control group. No obvious 
(a) 
(b) 2 
FIG. 2. Safranin-O-staining of the femoral condyl and tibial plateau from the knee joint of the rabbits with OA (4 weeks 
after surgery). (a) femoral condyle; (b) tibial plateau; left, medial; right, lateral. 
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(a )  " . 
(b )  
Fro. 3. (a) Safranin-O-stained femoral condyle at 2 weeks after surgery. Left column, saline-treated control; middle 
column, 1% HA80 (MW: 0.8 × 106 Da) treatment; right column,. 1% HA190 (MW: 1.9x 106 Da) treatment. Upper row, 
original magnification ×10; lower row, original magnification x50. Eight histological parameters (loss of superficial layer, 
erosion of cartilage, fibrillation and/or fissures, loss of proteoglycan, disorganization of chondrocytes, loss of 
chondrocytes, exposure of subchondral bone, cluster formation) were evaluated according to the scoring system 
described in Materials and Methods. Scores for above eight parameters of three groups are judged as followed. 
Saline-treated: +4, +4, +4, +4, +4, +4, +1, +2. HA80-treated: +3, +2, +2, +4, +3, +2, +1, +2. HA190-treated: +2, +2, +2, 
+2, +2, +2, +1, +1. 
(b) Saf~anin-O-stained tibial plateau at 2 weeks after surgery. Left column, saline-treated control; middle colttmn, 1% 
HA80 (MW: 0.8xl06Da) treatment; right column, 1% HA190 (MW: 1.9xl0~Da) treatment. Upper row, original 
magnification xl0; lower row, original magnification x50. Eight histological parameters (loss of superficial layer, erosion 
of cartilage, fibrillation and/or fissures, loss of proteoglycan, disorganization of chondrocytes, loss of chondrocytes, 
exposure of subchondral bone, cluster formation) were evaluated according to the scoring system described in Materials 
and Methods. Scores for above eight parameters of three groups are judged as followed. Saline-treated: +2, +3, +2, +4, 
+4, +4, +1, +2. HA80-treated: +3, +3, +3, +4, +4, +4, +1, +1. HA190-treated: +1, +1, +1, +1, +1, +1, +1, +1. 
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(c) 
(d) 
FIG. 3. (c) Safranin-O-stained femoral condyle at 4 weeks after surgery. Left column, saline-treated control; middle 
column, 1% HA80, (MW: 0.8 x 10 e Da) treatment; right column, 1% HA190 (MW: 1.9 × 108 Da) treatment. Upper row, 
original magnification ×10; lower row original magnification x50. Eight histological parameters (loss of superficial layer, 
erosion of cartilage, fibrillation and/or fissures, loss of proteoglycan, disorganization of chondrocytes, loss of 
chondrocytes, exposure of subchondral bone, cluster formation) were evaluated according to scoring system 
described in the Materials and Methods. Scores for above eight parameters of three groups are judged as followed. 
Saline-treated: +4, +4, +4, +4, +4, +4, +1, +4. HA80-treated: +3, +3, +3, +3, , +2, +1, +3. HA190-treated: +1, +1, +1, 
+2, +2, +1, +1, +2. 
(d) Safranin-O-stained tibial plateau at 4 weeks after surgery. Left column, saline-treated control; middle column, 1% 
HA80 (MW: 0.8 ×106 Da) treatment; right column, 1% HA190 (MW: 1.9×10~Da) treatment. Upper row, original 
magnification ×10, lower row, original magnification ×50. Eight histological parameters (loss of superficial layer, erosion 
of cartilage, fibrillation and/or fissures, loss of proteogtycan, disorganization of chrondrocytes, loss of chondrocytes, 
exposure of subchondral bone, cluster formation) were evaluated according to the scoring system described in Materials 
and Methods. Scores for above eight parameters of three groups are judged as followed. Saline-treated: +4, +4, +4, +4, 
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FIG. 4. Global histopathological scores after intra-articular HA or saline injection. One percent solution of HA190 and 
HA80 was used. Values represent averages of six rabbits and standard eviation. Significance of intergroup differences 
were determined by the Wilcoxon's rank sum test. (a) femur; (b) tibia; • =control; A = HA80 (MW 0.8× 106 Da); 
[] = HA190 (MW 1.9 x 106 Da). *P < 0.05, **P < 0.01. 
osteochondrophytes were seen during the obser- 
vation period of this experiment. 
The results using histological grading showed a 
significant inhibition of degenerative changes in 
the cartilage by 1% HA190 treatment in an early 
stage. In the 1% HA190 treatment group, inhibition 
of cartilage degenerative changes was obvious in 
both the femoral condyle and the tibial plateau 2 
weeks after surgery. However, such effects were less 
marked 4 weeks after surgery in the tibial plateau 
(Fig. 4). These results indicate that repeated 
intra-articular administration of HA190 at a 
concentration of 1%, has a preventive ffect on 
the development of early cartilage degenerative 
changes. No evidence for osteochondrophyte for- 
mation was presently seen and a longer follow-up 
period study could be necessary to determine 
whether HA190 can prevent osteophyte formation. 
At a concentration of 1%, HA80 also signifi- 
cantly inhibited the development of cartilage 
degenerative changes, but the effect was only 
obvious 4 weeks after surgery and only for the 
femoral condyle. Two weeks after surgery, the 
global score of HA80 treated animals was not 
significantly different from that of the saline 
treated group (Fig. 4). The HA80 treatment did not 
result in a significant inhibition of degenerative 
changes in the cartilage of the tibial plateau, either 
2 or 4 weeks after surgery. Prevention of cartilage 
degeneration at 2 weeks was clearly better with 
HA190 than HA80, in both the femoral condyle and 
the tibial plateau. However, no significant differ- 
ence between the two HA preparations was 
observed at 4 weeks. These data indicate that the 
superiority of HA190 over HA80 in the inhibition 
of cartilage degenerative l sions is only obvious in 
the early stage of the experimental OA. The global 
score was generally not significantly reduced by 
HA190 at concentrations lower than 1%. In this 
study, 0.1 ml/kg HA190 at 1% concentration was 
the minimum effective dose for the prevention of 
cartilage degeneration. 
SEM observation revealed that animals of the 
saline-treated group developed superficial defects 
of the cartilage, fibrillation, fissures and erosion 
(Fig. 5). These SEM findings are in agreement with 
the histopathological findings and underscore the 
efficacy of high molecular weight HA to inhibit the 
development of degenerative changes in this 
experimental OA model. 
The mechanisms by which the cartilage degener- 
ation is prevented by HA are still unknown. The 
effect of the variations in the molecular weight of 
HA on cartilage metabolism is thus poorly 
understood. Shimazu et al. [20] reported that HA 
inhibition of proteoglycan release by chondrocyte 
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FIG. 5. Scanning electron micrograph of the articular plane of the femoral condyle at 2 weeks after surgical procedures. 
(A) normal joint group; (B) saline-treated control group; (C), 1% HA190-treated group. (Bar= 100 ttm). 
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Table IV. 
Histopathological scores after intra-articular HA or saline injection 
2 Weeks 4 Weeks 
Saline HA-80 HA-190 Saline HA-80 HA-190 
Femur 
Loss of superficial layer 
Erosion of cartilage 
Fibrillation and/or fissures 
Loss of proteoglycan 
Disorganization of chondrocytes 
Loss of chondrocytes 
Exposure of subchondral bone 
Cluster formation 
Tibia 
Loss of superficial layer 
Erosion of cartilage 
Fibrillation and/or fissures 
Loss of proteoglycan 
Disorganization of chondrocytes 
Loss of chondrocytes 
Exposure of subchondral bone 
Cluster formation 
3.0 2.7 2.0 3.5 2.8 2.7 
2.8 2.2 2.0 3.8 3.0 2 .3*  
3.0 2.7 2.0 3.7 2.7* 2.5* 
3.7 3.5 2.5* 3.8 3.7 3.2 
3.3 3.0 2.2* 3.8 3.2 2.7* 
3.2 2.3 1.8" 3.3 2.2* 1.8" 
1.0 1.0 1.0 1.0 1.0 1.0 
2.5 2.0 1.5 2.7 2.3 1.8 
2.2 1.7 1.0 2.5 1.7 1.8 
2.5 1.8 1.0"* 2.5 2.2 1.7 
2.3 2.0 1.0"* 2.2 2.2 1.5 
3.2 3.0 1.3"* 3.5 3.0 2.7 
3.0 2.8 1.0"* 3.7 2.7 2.0** 
2.7 2.3 1.0"* 2.2 1.8 1.3 
1.0 1.0 1.0 1.0 1.0 1.0 
2.2 1.5 1.3 2.7 2.0 2.3 
One percent solution of HA190 and HA80 was used. Values represent averages of six rabbits. Significance of inter-group differences 
were determined by the Wilcoxon's rank sum test. (*P < 0.05, **P < 0.01.) 
cu l ture was dependent  upon the concentrat ion  and 
molecular  size of the molecule. The results of 
studies on the c learance of proteins from jo int  
cavity vary. Sl iwinski  et al. [21] reported that  
radiolabeled immunoglobul ins of var ious sizes 
were cleared from synovial  fluid independent ly  of 
thei r  molecu lar  weight. However, Sato et al. [22] 
found that  when two types of 14C-labeled HA 
(molecular weight: 0.9 x 106 Da and 1.8 × 106 Da) 
were in jected into the joints of rabbits, the 
retent ion  of the HA in the ar t icu lar  cavity after the 
in ject ion was dependent  upon its molecular  size. 
Destruct ion of cart i lage matr ix  in OA is known 
to be caused by a var iety of proteinases [23, 24]. 
The matr ix  metal loprote inases (MMPs), which are 
specif ically contro l led by t issue inhibi tors of 
metal loprote inases (TIMPs), are the most l ikely 
candidates [25, 26]. Yasui et al. [27] found that  HA 
induced TIMP-1 product ion by bovine chondro- 
cytes, and that  the effect was dependent  on the 
molecular  size of HA. It was reported by Sakamoto 
et al. [28] that,  due to t issue fibri l lation, HA could 
penetrate into the deep layer of OA cart i lage and 
could have a direct  access to chondrocyte 
membranes. Thus, HA might affect the catabol ic 
act ivity of chondrocytes through T IMP product ion.  
The present ly observed super ior i ty  of HA190 over 
HA80 in inhibit ing cart i lage degenerat ion could be 
explained by the differences observed in vitro in 
re lat ion with the molecular  weight of HA. 
The molecular  s ize-dependent effects of HA on 
the development of early degenerat ive OA changes 
observed in the present  study suggest hat  h igher  
molecu lar  weight HA is cl inical ly eff icacious in the 
t reatment  of inc ip ient OA. 
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